Laure B Bindels1, Jens Walter, Amanda E Ramer-Tait. 1. aDepartment of Food Science and Technology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA bDepartment of Agricultural, Food and Nutritional Science cDepartment of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
Abstract
PURPOSE OF REVIEW: Recent clinical trials and animal studies indicate that resistant starches may be beneficial therapeutic tools for the management of metabolic diseases. The purpose of this review is to summarize these findings and discuss the established and proposed mechanisms by which resistant starches exert their benefits. We also examine open questions regarding how resistant starches improve metabolism and propose future research directions for the field. RECENT FINDINGS: Data from both humans and animal models clearly support a role for resistant starches in improving a variety of metabolic features; however, discrepancies do exist regarding specific effects. Concomitant improvements in both insulin levels and body fat depots are often reported in rodents fed resistant starches, whereas resistant starch feeding in humans improves insulin sensitivity without having a major impact on fat mass. These differences could be explained by the coexistence of several mechanisms (both gut microbiota-dependent and gut microbiota-independent) underpinning the metabolic benefits of resistant starches. SUMMARY: Together, the studies presented in this review offer new insights into the potential pathways by which resistant starches enhance metabolic health, including modulation of the gut microbiota, gut peptides, circulating inflammatory mediators, innate immune cells, and the bile acid cycle.
PURPOSE OF REVIEW: Recent clinical trials and animal studies indicate that resistant starches may be beneficial therapeutic tools for the management of metabolic diseases. The purpose of this review is to summarize these findings and discuss the established and proposed mechanisms by which resistant starches exert their benefits. We also examine open questions regarding how resistant starches improve metabolism and propose future research directions for the field. RECENT FINDINGS: Data from both humans and animal models clearly support a role for resistant starches in improving a variety of metabolic features; however, discrepancies do exist regarding specific effects. Concomitant improvements in both insulin levels and body fat depots are often reported in rodents fed resistant starches, whereas resistant starch feeding in humans improves insulin sensitivity without having a major impact on fat mass. These differences could be explained by the coexistence of several mechanisms (both gut microbiota-dependent and gut microbiota-independent) underpinning the metabolic benefits of resistant starches. SUMMARY: Together, the studies presented in this review offer new insights into the potential pathways by which resistant starches enhance metabolic health, including modulation of the gut microbiota, gut peptides, circulating inflammatory mediators, innate immune cells, and the bile acid cycle.
Authors: Margarita S Dodevska; Sladjana S Sobajic; Predrag B Djordjevic; Vesna S Dimitrijevic-Sreckovic; Vesna V Spasojevic-Kalimanovska; Brizita I Djordjevic Journal: Eur J Nutr Date: 2015-01-15 Impact factor: 5.614
Authors: Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint Journal: ISME J Date: 2010-08-05 Impact factor: 10.302
Authors: C L Bodinham; L Smith; E L Thomas; J D Bell; J R Swann; A Costabile; D Russell-Jones; A M Umpleby; M D Robertson Journal: Endocr Connect Date: 2014-04-15 Impact factor: 3.335
Authors: Jibran A Wali; Annabelle J Milner; Alison W S Luk; Tamara J Pulpitel; Tim Dodgson; Harrison J W Facey; Devin Wahl; Melkam A Kebede; Alistair M Senior; Mitchell A Sullivan; Amanda E Brandon; Belinda Yau; Glen P Lockwood; Yen Chin Koay; Rosilene Ribeiro; Samantha M Solon-Biet; Kim S Bell-Anderson; John F O'Sullivan; Laurence Macia; Josephine M Forbes; Gregory J Cooney; Victoria C Cogger; Andrew Holmes; David Raubenheimer; David G Le Couteur; Stephen J Simpson Journal: Nat Metab Date: 2021-06-08
Authors: Ursula White; Courtney M Peterson; Robbie A Beyl; Corby K Martin; Eric Ravussin Journal: J Acad Nutr Diet Date: 2020-04-09 Impact factor: 4.910
Authors: Laure B Bindels; Rafael R Segura Munoz; João Carlos Gomes-Neto; Valentin Mutemberezi; Inés Martínez; Nuria Salazar; Elizabeth A Cody; Maria I Quintero-Villegas; Hatem Kittana; Clara G de Los Reyes-Gavilán; Robert J Schmaltz; Giulio G Muccioli; Jens Walter; Amanda E Ramer-Tait Journal: Microbiome Date: 2017-02-07 Impact factor: 14.650
Authors: Valentin Mocanu; Zhengxiao Zhang; Edward C Deehan; Dina H Kao; Naomi Hotte; Shahzeer Karmali; Daniel W Birch; Kalutota K Samarasinghe; Jens Walter; Karen L Madsen Journal: Nat Med Date: 2021-07-05 Impact factor: 53.440
Authors: Flora C Amagloh; Benard Yada; Gaston A Tumuhimbise; Francis K Amagloh; Archileo N Kaaya Journal: Molecules Date: 2021-05-17 Impact factor: 4.411
Authors: Michelle J Alfa; David Strang; Paramjit S Tappia; Nancy Olson; Pat DeGagne; David Bray; Brenda-Lee Murray; Brett Hiebert Journal: Front Med (Lausanne) Date: 2018-01-22